Cargando…
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived fro...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846723/ https://www.ncbi.nlm.nih.gov/pubmed/33514749 http://dx.doi.org/10.1038/s41541-021-00281-z |
_version_ | 1783644789460172800 |
---|---|
author | Baker, Sarah M. Settles, Erik W. Davitt, Christopher Gellings, Patrick Kikendall, Nicole Hoffmann, Joseph Wang, Yihui Bitoun, Jacob Lodrigue, Kasi-Russell Sahl, Jason W. Keim, Paul Roy, Chad McLachlan, James Morici, Lisa A. |
author_facet | Baker, Sarah M. Settles, Erik W. Davitt, Christopher Gellings, Patrick Kikendall, Nicole Hoffmann, Joseph Wang, Yihui Bitoun, Jacob Lodrigue, Kasi-Russell Sahl, Jason W. Keim, Paul Roy, Chad McLachlan, James Morici, Lisa A. |
author_sort | Baker, Sarah M. |
collection | PubMed |
description | Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived from B. pseudomallei grown in nutrient-rich media protects mice against lethal disease. Here, we evaluated if OMVs derived from B. pseudomallei grown under macrophage-mimicking growth conditions could be enriched with intracellular-stage proteins in order to improve the vaccine. We show that OMVs produced in this manner (M9 OMVs) contain proteins associated with intracellular survival yet are non-toxic to living cells. Immunization of mice provides significant protection against pulmonary infection similar to that achieved with a live attenuated vaccine and is associated with increased IgG, CD4(+), and CD8(+) T cells. OMVs possess inherent adjuvanticity and drive DC activation and maturation. These results indicate that M9 OMVs constitute a new promising vaccine against melioidosis. |
format | Online Article Text |
id | pubmed-7846723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78467232021-02-08 Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine Baker, Sarah M. Settles, Erik W. Davitt, Christopher Gellings, Patrick Kikendall, Nicole Hoffmann, Joseph Wang, Yihui Bitoun, Jacob Lodrigue, Kasi-Russell Sahl, Jason W. Keim, Paul Roy, Chad McLachlan, James Morici, Lisa A. NPJ Vaccines Article Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived from B. pseudomallei grown in nutrient-rich media protects mice against lethal disease. Here, we evaluated if OMVs derived from B. pseudomallei grown under macrophage-mimicking growth conditions could be enriched with intracellular-stage proteins in order to improve the vaccine. We show that OMVs produced in this manner (M9 OMVs) contain proteins associated with intracellular survival yet are non-toxic to living cells. Immunization of mice provides significant protection against pulmonary infection similar to that achieved with a live attenuated vaccine and is associated with increased IgG, CD4(+), and CD8(+) T cells. OMVs possess inherent adjuvanticity and drive DC activation and maturation. These results indicate that M9 OMVs constitute a new promising vaccine against melioidosis. Nature Publishing Group UK 2021-01-29 /pmc/articles/PMC7846723/ /pubmed/33514749 http://dx.doi.org/10.1038/s41541-021-00281-z Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Baker, Sarah M. Settles, Erik W. Davitt, Christopher Gellings, Patrick Kikendall, Nicole Hoffmann, Joseph Wang, Yihui Bitoun, Jacob Lodrigue, Kasi-Russell Sahl, Jason W. Keim, Paul Roy, Chad McLachlan, James Morici, Lisa A. Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title | Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_full | Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_fullStr | Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_full_unstemmed | Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_short | Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
title_sort | burkholderia pseudomallei omvs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846723/ https://www.ncbi.nlm.nih.gov/pubmed/33514749 http://dx.doi.org/10.1038/s41541-021-00281-z |
work_keys_str_mv | AT bakersarahm burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT settleserikw burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT davittchristopher burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT gellingspatrick burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT kikendallnicole burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT hoffmannjoseph burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT wangyihui burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT bitounjacob burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT lodriguekasirussell burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT sahljasonw burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT keimpaul burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT roychad burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT mclachlanjames burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine AT moricilisaa burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine |